Dermatology

Monday, October 26, 2026

1

Nivolumab Plus Relatlimab Maintains PFS and OS Advantage Over Nivolumab in Advanced Melanoma

Friday, October 23, 2026

1

Merck and Moderna Announced mRNA-based Therapy Reduced Recurrence and Death in Melanoma

Wednesday, October 21, 2026

1

Early Skin Toxicity May Signal Benefit From EV-Pembrolizumab in Retrospective Study

Tuesday, October 20, 2026

1

Bitopertin Met Primary and Secondary Endpoints in Phase 3 EPP Trial

Wednesday, October 14, 2026

1

Maternal Diet in Pregnancy Tied to Infant Colic Plus Eczema

Monday, October 12, 2026

1

FDA Approves Hovilpri, an Oral Helicase-Primase Inhibitor for Refractory HSV

2

Bimekizumab Responses Sustained Through 3 Years in Psoriatic Arthritis

3

Higher LDL Associated With Lower Secukinumab Response in Plaque Psoriasis

Friday, October 09, 2026

1

Undeclared Clobetasol Detected in 6 of 18 Online OTC Skin Products

Tuesday, October 06, 2026

1

Celltrion Launches a Biosimilar Designated as Interchangeable with Omalizumab (Xolair)

Wednesday, September 30, 2026

1

Pembrolizumab and Nivolumab Show Similar Outcomes in Advanced Melanoma in VA Cohort Study

Tuesday, September 15, 2026

1

Zasocitinib Gets Priority Review for Plaque Psoriasis

Thursday, September 10, 2026

1

Urticaria Control Commonly Led to Omalizumab Discontinuation

Thursday, September 03, 2026

1

HLA-A*32:01 Linked to Lamotrigine-Induced DRESS

Friday, August 28, 2026

1

First Oral Dermatomyositis Treatment Approved

Wednesday, August 26, 2026

1

FDA Approves Skyrizi for Pediatric Psoriatic Disease

Thursday, August 20, 2026

1

Intismeran Plus Pembrolizumab Meets Melanoma Endpoints

Monday, August 17, 2026

1

Pfizer-Valneva Lyme Vaccine Advances to EMA Review

Sunday, August 16, 2026

1

SKINVIVE Gains FDA Approval for Neck Appearance

Thursday, August 13, 2026

1

Phase 3 Trials Support Upadacitinib for Alopecia Areata

2

Daromun Extends RFS in Resectable Melanoma

Monday, June 29, 2026

1

PCOS Becomes Polyendocrine Metabolic Ovarian Syndrome

Loading